Lipid-sensing GPR183-KRAS signaling mediates T H 17 autoimmunity and identifies fluvoxamine repurposing in uveitis
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
These findings delineate a unique GPR183-KRAS–mitochondrial damage axis governing T H 17-driven autoimmunity and support repurposing FLV as a translatable therapeutic approach for AU and other autoimmune inflammatory disorders.
Appeared: Friday, October 30. Science Advances. Peer-reviewed journal.